ACR Convergence 2025 | Video: Rheuminations on Milestones & Ageism

Search results for: walking

Life, Happiness, and the Pursuit of Rheumatology

Simon M. Helfgott, MD | September 5, 2012

What makes rheumatologists such a happy group?

Inflammatory Myopathies in Children

Angela Byun Robinson, MD, and Ann M. Reed, MD | July 10, 2012

Treatment options and recent research for juvenile dermatomyositis.

A Fork in the Road: Advocacy for Rheumatology

Simon M. Helfgott, MD | July 10, 2012

Is that fork bent? So you must be a rheumatologist.

Coding Corner: Real-Life Rheumatology Note

Staff | July 9, 2012

A 46-year-old white female comes in for consultation on her arthritis pain.

The Complexity of Lumbar Spinal Stenosis

Jeffrey N. Katz, MD, MSc | June 10, 2012

Challenges in diagnosis and management.

Orthotics Part of Arthritis Treatment

Kurt Ullman | June 10, 2012

Although no cure, assistive devices can have an impact on pain of arthritis in the lower extremities

Reflections on Living with Lupus, and on Treating It

Simon M. Helfgott, MD | April 6, 2012

There are some people whose purpose in life is to entertain. Some of us are fortunate to have them as our patients.

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden | April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD | March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

Scientists Pinpoint Three HLA Proteins Linked to Seropositive Rheumatoid Arthritis

Carrie Printz | February 28, 2012

Researchers have identified five amino acids in three HLA proteins that explain most of the association between major histocompatibility complex (MHC) and seropositive rheumatoid arthritis (RA).